Reported adverse event during Covaxin phase 1 trial within 24 hours: Bharat Biotech

The statement was issued following a report by Economic Times which revealed that a serious adverse event was seen in a case during the Phase I trial of its indigenous Covid vaccine.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/336Ji9E
via IFTTT